Early outcomes of drug-coated balloon angioplasty and stent placement for the treatment of iliac artery lesions

ObjectiveThe efficacy and safety of drug-coated balloons (DCBs) in the treatment of aortoiliac artery stenosis or occlusion remains poorly explored.MethodsA single-center retrospective cohort study of patients diagnosed with iliac artery stenosis or occlusion who received either iliac artery DCB ang...

Full description

Saved in:
Bibliographic Details
Main Authors: Jia-Hao Wen, Chun-Min Li, Zhen-Yi Jin, Sheng-Xing Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Surgery
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2025.1598354/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849422368926072832
author Jia-Hao Wen
Chun-Min Li
Zhen-Yi Jin
Sheng-Xing Wang
author_facet Jia-Hao Wen
Chun-Min Li
Zhen-Yi Jin
Sheng-Xing Wang
author_sort Jia-Hao Wen
collection DOAJ
description ObjectiveThe efficacy and safety of drug-coated balloons (DCBs) in the treatment of aortoiliac artery stenosis or occlusion remains poorly explored.MethodsA single-center retrospective cohort study of patients diagnosed with iliac artery stenosis or occlusion who received either iliac artery DCB angioplasty or stent implantation was conducted at our institution. The patients were followed up 6 and 12 months postoperatively. Lower limb computed tomography angiography was performed during the follow-up period. The primary endpoint of the study was the primary patency at 6 and 12 months. Both the clinical and follow-up data were analyzed.Results50 patients underwent DCB angioplasty, while 71 received stent implantation. Demographic and lesion characteristics were comparable between the two groups (P > 0.05). However, the balloon diameter used in the DCB group was significantly smaller (6.42 ± 0.80 mm vs. 7.39 ± 0.97 mm, P < 0.001). The primary patency values 6 and 12 months postoperatively were 84.2% and 80.7% for the DCB group and 96.1% and 89.6% for the stent group, respectively with no significant difference between the two groups (P = 0.124). However, the 12-month patency in the common iliac artery segment for the DCB group was significantly lower than that for the stent group (75.0% vs. 97.3%, P = 0.006). Univariate and multivariate logistic analyses did not identify any factors associated with long-term patency.ConclusionSame as stents, DCBs maintained a favorable but lower patency rate across various calcification levels and different TASC Ⅱ classification in patients with aortoiliac artery stenosis or occlusion.
format Article
id doaj-art-6c8dc64613734cce8ed8f6768f10d9de
institution Kabale University
issn 2296-875X
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Surgery
spelling doaj-art-6c8dc64613734cce8ed8f6768f10d9de2025-08-20T03:31:07ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2025-07-011210.3389/fsurg.2025.15983541598354Early outcomes of drug-coated balloon angioplasty and stent placement for the treatment of iliac artery lesionsJia-Hao WenChun-Min LiZhen-Yi JinSheng-Xing WangObjectiveThe efficacy and safety of drug-coated balloons (DCBs) in the treatment of aortoiliac artery stenosis or occlusion remains poorly explored.MethodsA single-center retrospective cohort study of patients diagnosed with iliac artery stenosis or occlusion who received either iliac artery DCB angioplasty or stent implantation was conducted at our institution. The patients were followed up 6 and 12 months postoperatively. Lower limb computed tomography angiography was performed during the follow-up period. The primary endpoint of the study was the primary patency at 6 and 12 months. Both the clinical and follow-up data were analyzed.Results50 patients underwent DCB angioplasty, while 71 received stent implantation. Demographic and lesion characteristics were comparable between the two groups (P > 0.05). However, the balloon diameter used in the DCB group was significantly smaller (6.42 ± 0.80 mm vs. 7.39 ± 0.97 mm, P < 0.001). The primary patency values 6 and 12 months postoperatively were 84.2% and 80.7% for the DCB group and 96.1% and 89.6% for the stent group, respectively with no significant difference between the two groups (P = 0.124). However, the 12-month patency in the common iliac artery segment for the DCB group was significantly lower than that for the stent group (75.0% vs. 97.3%, P = 0.006). Univariate and multivariate logistic analyses did not identify any factors associated with long-term patency.ConclusionSame as stents, DCBs maintained a favorable but lower patency rate across various calcification levels and different TASC Ⅱ classification in patients with aortoiliac artery stenosis or occlusion.https://www.frontiersin.org/articles/10.3389/fsurg.2025.1598354/fullatherosclerosis obliteransiliac arterydrug-coated balloonstentendovascular therapy
spellingShingle Jia-Hao Wen
Chun-Min Li
Zhen-Yi Jin
Sheng-Xing Wang
Early outcomes of drug-coated balloon angioplasty and stent placement for the treatment of iliac artery lesions
Frontiers in Surgery
atherosclerosis obliterans
iliac artery
drug-coated balloon
stent
endovascular therapy
title Early outcomes of drug-coated balloon angioplasty and stent placement for the treatment of iliac artery lesions
title_full Early outcomes of drug-coated balloon angioplasty and stent placement for the treatment of iliac artery lesions
title_fullStr Early outcomes of drug-coated balloon angioplasty and stent placement for the treatment of iliac artery lesions
title_full_unstemmed Early outcomes of drug-coated balloon angioplasty and stent placement for the treatment of iliac artery lesions
title_short Early outcomes of drug-coated balloon angioplasty and stent placement for the treatment of iliac artery lesions
title_sort early outcomes of drug coated balloon angioplasty and stent placement for the treatment of iliac artery lesions
topic atherosclerosis obliterans
iliac artery
drug-coated balloon
stent
endovascular therapy
url https://www.frontiersin.org/articles/10.3389/fsurg.2025.1598354/full
work_keys_str_mv AT jiahaowen earlyoutcomesofdrugcoatedballoonangioplastyandstentplacementforthetreatmentofiliacarterylesions
AT chunminli earlyoutcomesofdrugcoatedballoonangioplastyandstentplacementforthetreatmentofiliacarterylesions
AT zhenyijin earlyoutcomesofdrugcoatedballoonangioplastyandstentplacementforthetreatmentofiliacarterylesions
AT shengxingwang earlyoutcomesofdrugcoatedballoonangioplastyandstentplacementforthetreatmentofiliacarterylesions